Mediators of Inflammation

Acute Lung Injury, Repair, and Remodeling: Pulmonary Endothelial and Epithelial Biology


Publishing date
10 Mar 2017
Status
Published
Submission deadline
21 Oct 2016

Lead Editor
Guest Editors

1University of Pittsburgh, Pittsburgh, USA

2Northwestern University, Chicago, USA


Acute Lung Injury, Repair, and Remodeling: Pulmonary Endothelial and Epithelial Biology

Description

Acute lung injury (ALI) is a life-threatening inflammatory lung disease, most commonly caused by pneumonia and sepsis. An unresolved cytokine storm caused by bacterial infection leads to detrimental effects such as neutrophil influx, capillary leakage, and edema. Despite extensive research, the underlying mechanisms are not fully understood and mortality rate of ALI remains unacceptably high (30–40%).

The lung epithelium and endothelium act as a protective barrier against invading microbes present in air or circulation. Understanding the regulation of barrier integrity and lung epithelial and endothelial immune responses is important for developing new therapeutic strategies for treating ALI.

We invite authors to contribute original research articles as well as review articles that will provide a deeper understanding of the role of lung epithelial and endothelial cells in the pathogenesis of ALI.

Potential topics include but are not limited to the following:

  • Recent discoveries regarding regulation of lung epithelial and endothelial barrier integrity
  • Cell death in lung epithelial and endothelial cells
  • Regulation of cytokine release in ALI
  • Receptor signaling in lung epithelial and endothelial cells
  • Lung epithelial and endothelial cell proliferation and migration
  • Genetic and epigenetic studies in ALI
  • Systemic disease-induced ALI
  • Stem cells in lung repair and remodeling

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 9081521
  • - Editorial

Acute Lung Injury, Repair, and Remodeling: Pulmonary Endothelial and Epithelial Biology

Yutong Zhao | Karen Ridge | Jing Zhao
  • Special Issue
  • - Volume 2017
  • - Article ID 6893560
  • - Research Article

AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin

Junting Cai | Jianxin Wei | ... | Jing Zhao
  • Special Issue
  • - Volume 2017
  • - Article ID 3415380
  • - Research Article

Inhibition of Murine Pulmonary Microvascular Endothelial Cell Apoptosis Promotes Recovery of Barrier Function under Septic Conditions

Lefeng Wang | Sanjay Mehta | ... | Sean E. Gill
  • Special Issue
  • - Volume 2016
  • - Article ID 9461289
  • - Research Article

Glutathione Peroxidase-1 Suppresses the Unfolded Protein Response upon Cigarette Smoke Exposure

Patrick Geraghty | Nathalie Baumlin | ... | Jeanine M. D’Armiento
  • Special Issue
  • - Volume 2016
  • - Article ID 5078627
  • - Review Article

MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence

Yugang Zhuang | Hu Peng | ... | Weiguo Chen
  • Special Issue
  • - Volume 2016
  • - Article ID 4158698
  • - Research Article

Association of Heme Oxygenase 1 with Lung Protection in Malaria-Associated ALI/ARDS

Marcelo L. M. Pereira | Luana S. Ortolan | ... | Sabrina Epiphanio
  • Special Issue
  • - Volume 2016
  • - Article ID 7349603
  • - Research Article

NEMO-Binding Domain Peptide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting the NF-κB Signaling Pathway

Jianhua Huang | Li Li | ... | Wenjie Huang
  • Special Issue
  • - Volume 2016
  • - Article ID 5813794
  • - Research Article

Protective Effect of Galectin-1 during Histoplasma capsulatum Infection Is Associated with Prostaglandin E2 and Nitric Oxide Modulation

Lílian Cataldi Rodrigues | Adriana Secatto | ... | Marcelo Dias-Baruffi
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.